Plain-English translation of NCT05985668 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing new blood tests designed to more accurately diagnose platelet function disorders — conditions where the blood's clotting cells don't work properly. Researchers are comparing these novel tests against standard testing methods in patients who either have a known platelet disorder or are being evaluated for one. The goal is to help doctors identify these disorders more reliably so patients can get the right treatment faster.
Current tests for platelet disorders can be unreliable or miss diagnoses entirely, leaving patients with bleeding problems confused and untreated. This study aims to validate better, more accurate testing methods to improve how doctors diagnose these conditions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will provide blood samples that will be tested using both the new diagnostic methods and standard tests to see which ones work best. Depending on whether you have a confirmed or suspected platelet disorder, your participation may involve single or multiple visits to the hospital. The researchers will compare your test results to determine if the new tests are more accurate at identifying platelet disorders.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
Sweden
Sponsor
Region Stockholm
Collaborators
Karolinska Institutet
Enrollment target
~140 participants
Started
September 2023
Primary completion
December 2026
Age range
12 Months and older
Last updated on clinicaltrials.gov in December 2023.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.